Hermetica Superfood Encyclopedia
The Short Answer
Clove's essential oil is dominated by eugenol (≈79% of volatile oil), which exerts antimicrobial, analgesic, and antioxidant effects through free radical scavenging, membrane disruption, and enzyme inhibition, while the chromones biflorin and isobiflorin suppress inflammatory signaling via STAT1 inactivation. In vitro antimicrobial assays demonstrate 93–100% microbial inhibition at eugenol concentrations as low as 0.06%, supporting its longstanding role as a dental antiseptic and analgesic in Indonesian Jamu and global ethnomedicine.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keywordclove benefits
Clove — botanical close-up
Health Benefits
**Dental Analgesia and Oral Antisepsis**
Eugenol (≈79% of clove EO) reversibly blocks voltage-gated sodium channels and disrupts bacterial cell membranes, producing local anesthetic and broad-spectrum antimicrobial effects that underpin clove's use for toothache relief and oral infections in Jamu and Western dentistry.
**Antioxidant Activity**
Eugenol and phenolic compounds including ellagic acid, kaempferol, and rhamnetin donate hydrogen atoms to neutralize reactive oxygen species and upregulate endogenous antioxidant enzymes, with clove ranking among the highest-ORAC botanicals measured in vitro.
**Anti-Inflammatory Effects**
The chromones biflorin and isobiflorin inactivate STAT1 in LPS-stimulated macrophages, reducing pro-inflammatory cytokine cascades; β-caryophyllene (≈11.6% of EO) additionally acts as a selective CB2 receptor agonist to modulate peripheral inflammation.
**Antimicrobial and Antifungal Action**: Clove EO at 0
04–0.06% concentrations achieves 93–100% inhibition of tested bacterial strains in vitro through membrane permeabilization and inhibition of bacterial efflux pumps and ATPase activity, with activity extending to Candida species and dermatophytes.
**Hypoglycemic Potential**
Oleanolic acid and maslinic acid (triterpenoids) inhibit α-glucosidase and improve insulin receptor sensitivity in preclinical models, suggesting a role in postprandial glucose modulation, though human dose-response data remain limited.
**Analgesic and Neuroprotective Properties**
Eugenol modulates TRPV1 (transient receptor potential vanilloid 1) channels and suppresses prostaglandin synthesis via COX inhibition, reducing pain signaling; preclinical rodent models indicate neuroprotective effects against oxidative neuronal damage.
**Antiulcer and Gastroprotective Activity**
Eugenol reduces gastric acid secretion and promotes mucus production by modulating H+/K+-ATPase activity and upregulating prostaglandin E2, with preclinical gastric ulcer models showing significant lesion reduction, though clinical translation is unconfirmed.
Origin & History
Natural habitat
Syzygium aromaticum is indigenous to the North Moluccas (Maluku Islands) of Indonesia, where it thrives in tropical, humid climates with rich volcanic soils at low to moderate elevations. The tree is an evergreen of the Myrtaceae family, cultivated widely across Indonesia, Madagascar, Tanzania (Zanzibar), Sri Lanka, and India for its aromatic dried flower buds. Traditional cultivation relies on hand-harvesting of unopened buds before flowering, which are then sun-dried to yield the commercial spice.
“Clove has been traded as a precious commodity for over 2,000 years, originating in the Maluku Islands of Indonesia and reaching ancient Rome, China, and the Arab world via spice trade routes as early as the Han Dynasty (206 BCE–220 CE), when courtiers reportedly held cloves in their mouths to freshen breath before addressing the emperor. In Indonesian Jamu—the archipelago's traditional herbal medicine system—clove buds and their essential oil have been central ingredients for dental pain relief, antisepsis, and respiratory complaints for centuries, and clove remains one of Indonesia's most economically significant agricultural exports. Ayurvedic medicine classifies clove (Lavanga) as a warming, pungent herb used to kindle digestive fire (agni), relieve vomiting, and address respiratory congestion, while Traditional Chinese Medicine employs it (Ding Xiang) to warm the middle burner, descend rebellious qi, and treat hiccup and nausea. The 15th-century European spice trade, during which cloves commanded prices equivalent to gold by weight, drove the Age of Exploration and was a proximate cause of Portuguese, Dutch, and Spanish colonization of the Maluku Islands.”Traditional Medicine
Scientific Research
The evidence base for Syzygium aromaticum is predominantly preclinical, comprising in vitro antimicrobial assays, cell-culture inflammatory models, and rodent studies, with no well-powered randomized controlled trials identified in the current literature. GC-MS characterization studies consistently confirm eugenol dominance (70–80% of EO) and establish antimicrobial minimum inhibitory concentrations, but these in vitro findings have not been systematically translated to human clinical endpoints. The anti-inflammatory activity of biflorin and isobiflorin via STAT1 inactivation has been demonstrated in macrophage cell lines, and molecular docking analyses report binding affinities (e.g., α-farnesene at −7.2 to −7.4 kcal/mol to relevant targets), but these computational predictions require experimental and clinical validation. Eugenol's use as a dental analgesic has the longest clinical precedent and is recognized in pharmacopoeial monographs, yet quantified human trial data on sample sizes, effect sizes, and standardized dosing regimens remain sparse in the peer-reviewed literature.
Preparation & Dosage
Traditional preparation
**Whole Dried Buds (Culinary/Traditional)**
1–3 g of ground clove buds per day as a culinary spice, consistent with historical Jamu and Ayurvedic practice; no established therapeutic ceiling at this dose
**Essential Oil (Topical/Dental)**
0.5–1% eugenol-standardized clove EO diluted in a carrier oil for topical dental application; used neat (undiluted) only by dental professionals due to mucosal irritation risk.
**Standardized Extract (Oral Supplement)**
125–500 mg/day used in preclinical-extrapolated human protocols; no formally established human therapeutic dose
Hydroalcoholic or ethanolic extracts standardized to ≥70% eugenol content, with experimental doses of .
**Essential Oil (Antimicrobial/In Vitro Reference)**
Concentrations of 0.04–0.06% demonstrate 93–100% microbial inhibition in vitro; direct translation to oral dosing equivalents has not been established.
**Steam-Distilled EO (Aromatherapy)**
100 mL water for inhalation applications; internal use requires professional supervision
Diffusion at 2–5 drops per .
**Standardization Note**
European Pharmacopoeia requires >7.4% EO yield from dried buds; quality products should meet this specification and confirm eugenol content ≥75% by GC analysis.
Nutritional Profile
Dried clove buds provide approximately 274 kcal/100 g, with macronutrient composition of roughly 13 g protein, 13 g fat (including sterols campesterol and stigmasterol), and 66 g total carbohydrate including significant dietary fiber (~34 g). Micronutrient content is notable for manganese (≈60 mg/100 g, >2,600% DV), vitamin K (~142 µg/100 g), vitamin C (~80 mg/100 g), magnesium (~259 mg/100 g), calcium (~632 mg/100 g), and iron (~11.8 mg/100 g), though these concentrations are relevant only at supplemental rather than typical culinary intakes. The phytochemical matrix includes essential oil (8.9% of dry weight), dominated by eugenol (79.21%), β-caryophyllene (11.60%), and eugenol acetate (6.27%), alongside flavonoids (kaempferol, rhamnetin, eugenitin), tannins (ellagic acid, bicornin), triterpenoids (oleanolic acid, maslinic acid), and chromones (biflorin, isobiflorin). Eugenol bioavailability is enhanced by lipophilic formulations and reduced by high-fiber matrices; the compound undergoes extensive hepatic conjugation via glucuronidation and sulfation, yielding metabolites excreted renally.
How It Works
Mechanism of Action
Eugenol, constituting approximately 79% of clove essential oil, exerts its primary pharmacological effects through multiple concurrent pathways: it scavenges free radicals via its phenolic hydroxyl group, inhibits cyclooxygenase (COX-1 and COX-2) enzymes to reduce prostaglandin synthesis, and disrupts microbial membrane integrity by intercalating into phospholipid bilayers, compromising membrane potential and ion transport. The sesquiterpene β-caryophyllene (≈11.6% of EO) selectively binds cannabinoid receptor type 2 (CB2) without psychoactivity, attenuating NF-κB-mediated inflammatory gene transcription in immune cells. Biflorin and isobiflorin, chromone glycosides unique to Syzygium species, specifically inactivate STAT1 phosphorylation in LPS-stimulated macrophages, reducing interferon-γ-driven inflammatory amplification. Triterpenoids including oleanolic acid and maslinic acid competitively inhibit intestinal α-glucosidase and may enhance GLUT4 translocation, contributing to the observed hypoglycemic activity in preclinical assays.
Clinical Evidence
No large-scale randomized controlled trials specifically examining Syzygium aromaticum supplementation in human subjects were identified in the current evidence review, leaving clinical conclusions heavily dependent on extrapolation from preclinical and in vitro data. The most clinically grounded application is dental analgesia and antisepsis using eugenol-containing preparations, which have long-standing pharmacopoeial recognition and are embedded in standard dental practice (e.g., zinc oxide-eugenol cements), though formal RCT quantification of effect sizes in these settings is limited. Preclinical hypoglycemic and anti-inflammatory outcomes are promising but lack Phase II or Phase III human trial confirmation with defined endpoints, comparators, or adverse event monitoring. Confidence in clove's bioactive effects is moderate for antimicrobial and antioxidant properties based on consistent in vitro replication, but low-to-preliminary for systemic benefits such as neuroprotection, anti-obesity, and immunomodulation without supporting human data.
Safety & Interactions
Clove essential oil applied undiluted to oral mucosa can cause chemical burns, contact dermatitis, and mucosal necrosis; topical concentrations above 1% eugenol are associated with irritation and should be used only under professional dental supervision. Eugenol inhibits platelet aggregation through thromboxane A2 suppression and may potentiate the effects of anticoagulant and antiplatelet drugs (warfarin, clopidogrel, aspirin), increasing bleeding risk; it also inhibits CYP2C9 and CYP3A4 isoenzymes in vitro, raising theoretical concerns for interactions with drugs metabolized by these pathways, though clinical significance at typical dietary doses is unconfirmed. Ingestion of large quantities of clove oil (>5 mL) has caused acute hepatotoxicity, seizures, and metabolic acidosis in case reports, particularly in children; clove oil is considered unsafe for internal use in infants and young children. Pregnancy and lactation safety is unestablished beyond culinary use; high-dose eugenol exhibits uterotonic properties in animal models, and supplemental clove preparations should be avoided during pregnancy without medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Syzygium aromaticum (L.) Merr. & L.M.PerryEugenia caryophyllataCengkeh (Indonesian)Lavanga (Ayurveda)Ding Xiang (Traditional Chinese Medicine)Clous de girofle (French)
Frequently Asked Questions
What is eugenol in clove and what does it do?
Eugenol is the dominant bioactive compound in clove essential oil, comprising approximately 79% of its volatile constituents as confirmed by GC-MS analysis. It functions as a local anesthetic by blocking voltage-gated sodium channels, an antimicrobial agent by disrupting bacterial cell membranes, and an antioxidant by donating hydrogen atoms to neutralize free radicals, explaining clove's traditional use for toothache and infection.
Is clove oil safe to apply directly to a toothache?
Clove essential oil should not be applied undiluted (neat) to oral tissues by laypersons, as eugenol concentrations above 1% can cause chemical burns, mucosal necrosis, and contact dermatitis. For toothache relief, diluting 1–2 drops of clove EO in a teaspoon of carrier oil (e.g., olive oil) before applying to the affected area with a cotton swab is the safer approach, and professional dental consultation is always recommended for persistent dental pain.
What are the anti-inflammatory compounds in clove?
Clove contains multiple anti-inflammatory compounds acting through distinct mechanisms: β-caryophyllene (≈11.6% of EO) acts as a selective CB2 cannabinoid receptor agonist suppressing NF-κB signaling, while the chromones biflorin and isobiflorin specifically inactivate STAT1 phosphorylation in LPS-stimulated macrophages to reduce interferon-driven inflammation. Eugenol additionally inhibits COX-1 and COX-2 enzymes, reducing prostaglandin synthesis in a mechanism similar to non-steroidal anti-inflammatory drugs.
Can clove lower blood sugar?
Preclinical evidence suggests clove's triterpenoids, particularly oleanolic acid and maslinic acid, can inhibit intestinal α-glucosidase and may enhance insulin sensitivity in animal models, pointing to potential hypoglycemic activity. However, no well-designed randomized controlled trials in humans have established a therapeutic dose, confirmed clinical effect size, or demonstrated safety for this application, so clove should not be used as a replacement for prescribed antidiabetic medications.
Does clove interact with blood thinners or medications?
Yes, eugenol inhibits platelet aggregation by suppressing thromboxane A2, which can potentiate the anticoagulant effects of warfarin, clopidogrel, and aspirin, increasing bleeding risk—particularly at supplemental doses beyond typical culinary use. Eugenol also inhibits hepatic CYP2C9 and CYP3A4 enzymes in vitro, theoretically raising plasma levels of drugs metabolized by these pathways (e.g., statins, certain anticonvulsants, immunosuppressants), though the clinical significance of this interaction at dietary clove intake levels has not been formally quantified.
What is the difference between clove powder, clove oil, and clove extract supplements?
Clove powder contains the whole dried bud with all constituents intact but has lower eugenol concentration (≈3-5% by weight) and slower bioavailability compared to standardized extracts. Clove essential oil is highly concentrated (≈79% eugenol) and acts rapidly for topical use but carries higher potency and burn risk if applied undiluted. Standardized clove extracts offer a middle ground with controlled eugenol content (typically 40-95%), predictable dosing, and better bioavailability than powder while safer than pure essential oil.
Is clove safe to use during pregnancy and breastfeeding?
Clove as a culinary spice in food is generally recognized as safe during pregnancy, but concentrated clove oil and high-dose supplements should be avoided due to insufficient safety data and eugenol's potential uterotonic effects at high levels. Breastfeeding mothers should similarly limit intake to culinary amounts, as eugenol concentrations in breast milk from maternal supplementation remain understudied. Pregnant and nursing women should consult a healthcare provider before using clove supplements or essential oils.
What does clinical research show about clove's effectiveness for oral health compared to conventional antiseptics?
Clinical trials demonstrate that clove oil and eugenol are comparable to chlorhexidine and other conventional oral antiseptics for reducing oral bacterial counts and relieving toothache pain, with some studies showing faster onset of analgesia within 5-15 minutes of application. However, most studies are small-scale (n<100) and lack long-term follow-up data on sustained antimicrobial efficacy or periodontal disease prevention. While evidence supports clove's role as a complementary oral care agent, high-quality randomized controlled trials are needed to definitively establish superiority or equivalence to standard dental treatments.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w clove-syzygium-aromaticum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
